Announcements Trials
Browse Landscape

Phase

Phase NA 4Phase 1/2 1

Status

Completed 5Recruiting 4Active not recruiting 4Withdrawn 2

Sponsor Class

OTHER 5

Study Type

Interventional 5Observational 2

Sponsor

Cancer Type

Head & Neck 5

Conditions

Breast Neoplasms 5004Neoplasms 4197Prostatic Neoplasms 2428Carcinoma, Non-Small-Cell Lung 2265Colorectal Neoplasms 2053Lung Neoplasms 1705Multiple Myeloma 1459Lymphoma 1405Leukemia, Myeloid, Acute 1382Neoplasm Metastasis 1374Melanoma 1270Pancreatic Neoplasms 1200Leukemia 1196Ovarian Neoplasms 1192Lymphoma, Non-Hodgkin 1132Precursor Cell Lymphoblastic Leukemia-Lymphoma 1091Head and Neck Neoplasms 1056Leukemia, Lymphocytic, Chronic, B-Cell 994Lymphoma, Follicular 897Colonic Neoplasms 895Brain Neoplasms 876Stomach Neoplasms 857Recurrence 853Carcinoma, Hepatocellular 846Glioblastoma 841Lymphoma, Large B-Cell, Diffuse 771Rectal Neoplasms 759Uterine Cervical Neoplasms 728Carcinoma, Renal Cell 705Hodgkin Disease 698

Interventions

pembrolizumab 1Monitoring, Physiologic 1Docetaxel 1Behavior Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Completed × Interventional × Head and Neck Carcinoma × Clear all
NCT05115825 2026-02-27

Pain Management for Head and Neck Cancer Survivors

OHSU Knight Cancer Institute

Phase NA Completed
33 enrolled
Head & Neck

Head and Neck Carcinoma

NCT06079697 2025-12-12

An Exercise Prehabilitation Intervention for Improving Mobility and Recovery Outcomes in Patients Undergoing Head and Neck Cancer Surgery

OHSU Knight Cancer Institute

Phase NA Completed
52 enrolled
Head & Neck

Head and Neck Carcinoma

NCT05828004 2025-08-28

The SHINE-MDT Randomized Controlled Trial

West China Hospital

Phase NA Completed
233 enrolled
Head & Neck

Head and Neck Carcinoma

NCT03489252 2025-08-22

Remote Activity Monitored by Fitbit Charge 3 in Investigating Daily Step and Sleep Data in Participants With Head and Neck Cancer Undergoing Radiation Therapy

Thomas Jefferson University

Phase NA Completed
41 enrolled
Head & Neck

Head and Neck Carcinoma

NCT02718820 2024-01-09

Pembrolizumab Plus Docetaxel for the Treatment of Recurrent or Metastatic Head and Neck Cancer

Medical University of Vienna

Phase 1/2 Completed
22 enrolled 10 charts
Head & Neck

Head and Neck Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡